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Abstract 
Aims: The aims of this study were to explore the barriers to the implementation and 
progression of the Healthy Living Pharmacy (HLP) framework, from both provider 
and commissioner perspectives, and to ascertain whether the successes and barriers of 
the framework perceived by pharmacies are shared with commissioners. 
 
Methods: A structured qualitative interview study, using purposive sampling, was 
undertaken with 11 community pharmacists and 11 Healthy Living Champions 
(providers) from HLPs in the North of England. Four commissioners of such services 
were also interviewed.  Interviews were analysed using a thematic approach.   
 
Results: There were many aspects of the HLP framework that the service ‘providers’ 
were positive about namely: workforce development, engagement (particularly with 
the smoking cessation service), and as a motivation for pharmacy teams. However, 
there were areas of concern about low awareness amongst pharmacy users, the time 
involved in delivery, as well as financial considerations. These were exemplified by 
the health checks element. Commissioners also expressed concerns about health 
checks as well as a lack of cohesion between commissioners and service providers 
and a poor understanding of the broader framework.  
 
Conclusion: The HLP framework was perceived as valuable by providers although 
there were areas of concern. A key barrier to the framework – perceived by both 
providers and commissioners – was the implementation of health checks. This should 
be considered in future commissioning.   
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Introduction 
Community pharmacies have emerged in recent years as strategically important 
settings with great potential for delivering public health services.  One advantage of 
community pharmacies compared to other healthcare providers is the reach into the 
population: an estimated 90 per cent of the population make at least one visit per 
year,1 suggesting they have the potential to not only target patients with long-term 
conditions, but also those who do not interact with other healthcare professionals. 
Crucially, in England, it has been shown that the distribution of community 
pharmacies are positively associated with areas of high deprivation – a so-called 
positive pharmacy care law.2 Community pharmacies, therefore, are ideally placed in 
the community to meet healthcare needs of the population and, potentially – through 
targeting patients that need healthcare the most – reducing certain health inequalities.  
This potential has been acknowledged: for example, the White Paper, Pharmacy in 
England: building on strengths, delivering the future, details how community 
pharmacists could play a greater role in delivering public health services.3 One idea 
was that community pharmacies could act as ‘healthy living’ centres, providing 
greater services to the local needs of the population.  
 
In view of this, there is now significant emphasis placed upon community pharmacies 
delivering patient-focused services, including promoting healthy lifestyles and 
modification of health-related behaviours, as well as providing medicine-related 
activities.  This change has been supported through the contractual framework for 
community pharmacy in England, which allows community pharmacists to deliver a 
range of patient-focused healthcare services.4 These include: offering treatments for 
minor ailments, providing support to patients with long-term conditions, offering 
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screening for individuals with high risk of vascular disease, and providing 
commissioned services based on the needs and health risks of the local population 
they serve.  
 
Building on the success of the community pharmacy contractual framework and the 
‘healthy living’ centre approach discussed in the White Paper, the Healthy Living 
Pharmacy (HLP) framework was established, which allows community pharmacies to 
deliver a portfolio of public health services tailored according to local need.5,6 The 
framework is designed around a tiered commissioning system with three levels, each 
delivering an increasingly sophisticated suite of services.7 The overarching themes of 
the different tiers of service are: health promotion (Level 1), health prevention (Level 
2) and health protection (Level 3).  Services are thus commissioned according to these 
activities with smoking, alcohol and weight management key areas of focus. To 
support the transformation from a community pharmacy to a HLP, there are three 
‘enablers’ that underpin the three levels of service. These are: workforce development 
and Healthy Living Champions (HLCs) (members of the pharmacy team who have 
undertaken specific additional training), on site premises fit for the delivery of the 
service, and engagement with other stakeholders (e.g. GPs, social care and public 
health professionals).   
 
At present, research suggests that HLPs have the potential of improving the health of 
some patient groups compared to non-HLPs.8 However, despite an understanding 
around barriers associated with implementation, there is little known about the 
challenges associated with progressing between levels of the framework (notably 
from Level 1 to 2) or the views of commissioners responsible for commissioning 
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these services.  The aim of this study was, therefore, to explore the barriers to the 
implementation and progression of the HLP framework, from both pharmacy and 
commissioner perspectives, and to ascertain whether the successes and barriers of the 
framework perceived by pharmacies are shared with commissioners. 
 
Methods 
A structured qualitative interview study was undertaken with the following 
participants based in the North of England: 
• Community pharmacists working in Healthy Living Pharmacies  
• Healthy Living Champions working in Healthy Living Pharmacies 
• Commissioners who were responsible for commissioning services from 
Healthy Living Pharmacies 
For the purposes of the study, a community pharmacist was defined as a registrant of 
the General Pharmaceutical Council, a Health Living Champion was defined as a 
member of the pharmacy team with a Level 2 qualification in Understanding Health 
Improvement, as accredited by the Royal Society for Public Health (RSPH), while a 
commissioner was defined as an individual working within the Local Authority with 
responsibility for commissioning services from HLPs. 
  
Participants from HLPs (pharmacists or HLCs) were purposively sampled, according 
to the ward-level unemployment data as a proxy for relative deprivation of the 
community pharmacy9 and, if they were progressing to the next tier of the framework.  
Community pharmacies in areas with unemployment of under 6 per cent were 
classified as low deprivation, unemployment between 6 and 10 per cent as medium 
deprivation, and unemployment over 10 per cent as high deprivation.  Commissioners 
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were sampled according to their specific area of responsibility (e.g. smoking, alcohol 
or weight management).  
 
Among the 22 HLPs in the study region, interviews were carried out at 11: five in 
those progressing to Level 2 and six in those remaining at Level 1 (Table 1).  In each 
HLP, a pharmacist and HLC were interviewed. 
 
Table 1: Code names for pharmacies where interviews were carried out, showing 
ward level per cent unemployment as a proxy for deprivation 
 
Pharmacy 
code 
Deprivation 
level 
Ward level % 
unemployed 
Progressing to 
Level 2? 
Pharmacy 1 Low 5.9 Yes 
Pharmacy 2 Low 4.8 No 
Pharmacy 3 Low 5.4 No  
Pharmacy 4 Low 5.9 No 
Pharmacy 5 Medium 8.3 Yes 
Pharmacy 6 Medium 9.4 Yes 
Pharmacy 7 Medium 6.6 No 
Pharmacy 8 Medium 7.1 No 
Pharmacy 9 High 12.1 Yes 
Pharmacy 10 High 12.3 Yes 
Pharmacy 11 High 11.5 No 
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Interviews were also conducted with four members of a Local Authority responsible 
for commissioning the HLP framework; specifically, the heads of the smoking 
cessation, weight management, substance misuse and health checks aspects of the 
framework.  These four individuals were selected as smoking, alcohol use and obesity 
are the three most significant social determinants of health, and the health checks 
comprise a major aspect of the framework.  Data collection took place between May 
and August 2014.  
 
A structured-interview approach was adopted, to ensure that each respondent was 
asked exactly the same questions, keeping to the same wording for each interview.  
This consistency minimised error, as even small changes to wording can exert impact 
on responses.10 The interview schedule was developed after informal meetings with 
community pharmacists working in HLPs, and commissioners.  The interview 
questions were then piloted with one commissioner and two community pharmacists 
and, based on feedback modified for the main set of interviews.  The interview 
questions for community pharmacists and HLCs are outlined in Box 1 and those for 
commissioners in Box 2. 
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Box 1: Interview questions for community pharmacists and HLCs 
 
 
  
1. What were your expectations when you decided to become a HLP? 
2. Can you describe the impact on your pharmacy brought about by the HLP 
framework? 
3. Are there any aspects of the framework you consider to have been a 
success/what are the strengths to the framework? 
4. Are there any aspects of the framework you consider to be barriers to its 
success/what has been most challenging? 
5. As a pharmacy you are progressing on the framework from L1 to L2; could 
you outline your reasons for this decision? or 
6. As a pharmacy, having achieved L1 you are not progressing on the 
framework to L2; could you outline your reasons for this decision? 
7. How have you found it delivering the health checks? 
8. Has there been any feedback from your clients about the HLP? 
9. As the HLP scheme is new, did you feel you had enough support in 
implementing the framework? 
10. Is there anything you would like to see changed to the HLP framework based 
on your experience? 
11. Any further comments about any aspect of the HLP framework and its 
delivery in this pharmacy? 	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Box 2: Interview questions for commissioners  
 
  
	  
1. What were your expectations of the HLP framework? 
2. Can you describe the impact you perceive the HLP to have had on the 
pharmacies on the scheme? 
3. Are there any aspects of the framework in general that you consider to have 
been a success? 
4. Are there any aspects of the framework in general you consider to be 
barriers to its success? 
5. A number of pharmacies that achieved Level 1 are not progressing on the 
framework to Level 2; could you outline your thoughts for why this might 
be? 
6. What are your thoughts on health checks? Are they an important part of the 
framework for informing the commissioning of specific services? 
7. Could you describe any feedback from the pharmacies about the HLP? 
8. Is there anything you would like to see changed to the HLP framework 
based on your experience? 
9. Any further comments about any aspect of the HLP framework? 	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The interview questions were designed to be balanced, to enable interviewees to 
express their own opinions and experiences of carrying out Level 1 of the HLP 
framework.  Ultimately, the questions invited the pharmacists and HLCs to describe 
the particular successes and barriers of the framework, based on their experience of 
framework delivery.   Each interview was carried out in a location chosen by the 
participant and lasted approximately 30 minutes.  Interviews were conducted up until 
the point of data saturation when no new themes were emerging.  
 
All interviews were recorded using a digital voice recorder and subsequently 
transcribed verbatim.  The typed transcript was reviewed by the interviewer and 
compared with the field notes made during the interview to ensure meaning had not 
been lost in the transcription process.  Interviews were analysed using a thematic 
approach.  This method of analysis captures patterns of responses within the data 
set.11 The following stages were undertaken: familiarisation with the data by re-
reading of the transcripts; generating initial codes, searching for themes; reviewing 
themes, defining themes and reporting themes.  This process was led by the primary 
researcher, but was reviewed by the research team who, discussed and confirmed 
coding and interpretation during regular project meetings. The project was approved 
by Durham University Geography Department Ethics Sub-committee; all participants 
gave informed, written consent, prior to the interview. 
 
Results 
‘Providers’: the benefits of the HLP 
There were many aspects of the HLP framework that the service ‘providers’ 
(community pharmacists and HLCs) were positive about, namely: workforce 
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development, engagement (particularly with the smoking cessation service), and as a 
motivation for pharmacy teams. Both pharmacists and HLCs reported very positive 
experiences of the workforce development and capacity elements of the HLP 
framework. In particular, the training for the HLCs, the Royal Society of Public 
Health (RSPH) Level 2 Understanding Health Improvement award, was appreciated 
as it brought knowledge and expertise to non-pharmacists, meaning that more 
members of the pharmacy team are able to answer questions and distribute 
knowledge: ‘Training has been beneficial…everyone has gained something for career 
development’ (Pharmacist from HLP 6). 
 
There was also a positive theme that the HLP framework had been beneficial to 
engagement and accessibility with pharmacy users. Many pharmacies described 
becoming more proactive in approaching people with health promotion since joining 
the HLP framework.  This was thought to be due to the combination of training, 
which increased the knowledge and expertise of staff at pharmacies, and the health 
promotion zone, which roused interest and stimulated questions: ‘It has definitely 
positively affected engagement, pretty much everyone is approached about 
something’ (Pharmacist from HLP 6).  
 
Smoking cessation emerged strongly as the most well-used and successful aspect of 
the framework. When asked to describe the general successes of the framework, stop 
smoking was the most common response.  This describes a dual benefit in that it is an 
effective service and it brings business revenue to the pharmacy: ‘Stop smoking – it 
works and everybody is aware of it. It’s a great professional income source’ (Healthy 
Living Champion from HLP 11).  
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Many pharmacies valued the HLP framework in that it served as motivation, 
encouragement and recognition that pharmacies have the potential to be far more than 
just dispensing hubs.  A strong pattern emerged in that those, whose expectations of 
the HLP framework had been to offer more health promotion and a greater range of 
services, found that their expectations had been met.  Comments made by various 
participants throughout the interviews included:  ‘helping people improve their life’, 
‘motivate the team’, ‘enhance services’ and ‘recognition for what we already do’.  
 
Barriers to implementing the HLP 
However, there were areas of concern amongst pharmacists and HLCs - about low 
awareness, the time involved in delivery, and financial considerations. These were 
exemplified by the health checks element - and some of these concerns were shared 
by commissioners. Many pharmacies described a lack of awareness of HLP as a 
primary barrier to success. When asked to describe the impact of HLP Level 1 on the 
local community, many responded that a lack of awareness prevented people from 
taking full advantage of the services available at HLPs: ‘Awareness is low, I don’t 
think many of our customers know we’re HLP’ (Healthy Living Champion from HLP 
4).   
 
They also stated that a significant challenge posed by the HLP framework was the 
extra time it demanded.  When asked to describe the impact on the pharmacy 
workforce, many pharmacies described an increased workload due to increased 
administration, keeping up with promotions, performing the health checks and 
smoking cessation consultations, and losing staff to go on additional training courses: 
‘I’ve had to employ more people to cope with the increased workload; we are now 
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overstaffed in terms of prescription volumes as we’re too busy doing HLP’ 
(Pharmacist from HLP 10). 
 
Some pharmacists described being disappointed that the framework had not been 
beneficial from a business perspective. In particular, those who described their 
expectations of the framework to increase the number of customers were dissatisfied. 
Financial concerns were commonly stated as the reasoning for declining Level 2: 
‘There’s nothing to be gained by it and in this economic climate we can’t afford to 
lose staff for training’ (Pharmacist from HLP 4).   
 
These concerns were most apparent in regard to the health checks – which were seen 
as a common barrier by both pharmacists and HLCs. The issues were threefold: 
firstly, giving up the time to perform them; secondly, recruiting enough people to 
reach the target of 60 full health checks; and, thirdly, significant problems with IT 
needed to undertake the checks. Conducting the health checks was another common 
reason stated by pharmacies for not continuing to Level 2 of the framework: 
‘Delivering them is fine; recruitment is difficult. Our footfall for opportunistic people 
is low. All our regulars are on medication and so don’t qualify’ (Pharmacist from 
HLP 6).  
Commissioners also raised concerns about the very concept of health checks, with 
reference to the literature demonstrating no evidence of health checks reducing 
mortality or morbidity: ‘It’s a mandated service, it’s written into law…so whatever I 
think of it, I have to commission a programme…I’d like them to disconnect the HLP 
framework from the health checks programme, I think they should be separate’ 
(Commissioner D).  
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The interviews with commissioners also highlighted other barriers – on the 
commissioning side - most notably a lack of cohesion between commissioners and 
service providers and a poor understanding of the broader framework. The aspirations 
of commissioners were narrowly focused only on the specific aspect they 
commissioned e.g. increasing smoking cessation numbers. There was little connection 
with the different priorities held by pharmacy staff, whose aspirations were to 
promote health more generally through their pharmacy as well as increase business.   
In terms of understanding of the broader framework, it became clear that the 
commissioners only had knowledge about the specific aspect they were 
commissioning, and generally had a poor understanding of the wider framework. For 
example, when asked to comment on the general successes of the framework, none of 
the commissioners felt well enough informed to offer any comment.  This suggests 
that those commissioning individual aspects of the framework do not have a holistic 
perspective on HLP, and therefore cannot appreciate fully the pressures and needs of 
those delivering it: ‘Because I’m not involved in the rest of the framework and haven’t 
had any information shared I don’t know’ (Commissioner A). 
 
Discussion 
Our study identified four main benefits – as perceived by the providers – arising from 
the HLP framework, indicating that although these benefits are largely intangible, the 
HLP framework appears to be a valuable one.  The commissioners did not replicate 
these themes, although when it came to identifying barriers toward implementation 
there was commonality amongst themes.  Firstly, improvements to the development 
and capacity of pharmacy workers were reported, resulting from the training carried 
out through the HLP framework. Secondly, this study identified that engagement 
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between pharmacy workers and pharmacy users has improved, due to increased 
knowledge and expertise of staff, and by virtue of the wider range of services 
available at HLPs.  Thirdly, by becoming a HLP, this process had motivated and 
encouraged pharmacy teams.  And finally, providers also perceived the smoking 
cessation service as a valuable aspect to the HLP framework.  This supports previous 
research that has shown smoking cessation services delivered in a community 
pharmacy setting can be valuable.  These findings align with the trajectory of 
community pharmacy playing a key role in delivering public health services and 
supports previous work that showed HLPs have a positive impact on service 
development and staff training.5 
 
We also found several barriers to the framework – both in terms of the overall 
implementation and in progression to Level 2.  Indeed, the providers identified a lack 
of financial reward and the time required to deliver the services associated with the 
framework as barriers.  Similarly, Mackridge and colleagues also identified 
fluctuations in funding and increased workload as barriers toward delivering an 
alcohol identification and brief advice (IBA) service in a community pharmacy 
setting.12 Our work, although not directly associated with delivery of an IBA service, 
supports these findings.  Another barrier identified in our study was due to the 
perceived lack of awareness of the HLP framework by the general population.  This 
lack of awareness may not only impact on the number of patient’s receiving services, 
but also on the monetary outcomes the community pharmacy receives for offering the 
framework.  Providers reported this as a reason for not progressing to Level 2 of the 
framework.  If the HLP framework is to improve the health of more people there 
should be a campaign – possibly through the local and national media – to raise public 
	   16	  
awareness in the service.  Another reported barrier for not progressing to Level 2 of 
the framework was the health checks.  Many community pharmacies – particularly 
those located in areas of high deprivation – struggled with recruitment, and the time-
consuming nature of delivering them.  At present, at Level 1 of the framework, each 
HLP has to undertake 60 full health checks.  This can be challenging depending on 
the patient demographic using the community pharmacy.  Indeed, one pharmacist 
commented that the majority of the patients using the pharmacy were ineligible for 
the checks because they already have established heart disease.  The commissioners 
also raised concerns about the health checks: one described feeling ‘torn’ about the 
health check service, and that it should be ‘separated’ from the HLP framework.  This 
finding is timely as the effectiveness of health checks have been recently under 
debate; a recent review showed there is no evidence to support them.13 However, 
despite the lack of robust evidence of effectiveness, health checks are still 
incorporated into healthcare policy throughout the UK.  In many cases, it is possible 
the emotive rhetoric of individual success stories dominate the views of health check 
advocates; distinctions must therefore be made between ‘good evidence’ and ‘good 
stories’.14  
 
While we believe our results are robust and have important implications for the future 
commissioning of the HLP framework, we acknowledge that providers and 
commissioners were interviewed from only one region in the North of England and 
that this is a small-scale qualitative study.  Generalisation of this work to other 
regions of the UK and more widely should therefore only be made carefully. 
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Conclusion  
The HLP framework was perceived as valuable by providers and appeared to develop 
the workforce, which in turn, motivated the wider pharmacy team to approach 
patients about their health. However, there were areas of concern amongst 
implementation.  A key barrier to the framework – perceived by both providers and 
commissioners – was the implementation of health checks. This should be considered 
in future commissioning.   
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